Wed Jul 12 2023
This week, we’ll discuss the findings of a study that examined the prevalence of <i>KRAS</i> G12C mutations across different populations. Then, we’ll hear recent news about FDA oncology drug approvals in the month of January. Coverage...
Get AI-powered summaries and transcripts for any meeting, phone call, or podcast.
Available on iOS, Android, Mac, and Windows
No transcript available.
